Regulatory Framework and Functional Safety: Built on Compliance and Structural Integrity

In the evolving nutraceutical landscape, innovation must be accompanied by regulatory clarity and functional safety. Advanced formulation architecture requires not only scientific validation but also strict adherence to internationally recognized safety standards.

ABIMPROSYC has been developed within a compliance-driven framework aligned with major global regulatory systems.

All ingredients used in the formulation meet eligibility and safety standards under:

GRAS (21 CFR §170.30 – U.S. FDA)

Novel Food Regulation (Regulation (EU) 2015/2283 – European Union)

Natural Health Products Directorate (Health Canada, NHPD)

This multi-jurisdictional compliance model reinforces ingredient transparency, traceability, and safety validation.

Designed Without Pharmacological Mechanisms

ABIMPROSYC does not contain pharmacological agents.

The formulation:

Does not induce active therapeutic mechanisms

Does not rely on prescription-based compounds

Does not function as a drug or biologic product

Does not require medical prescription

Its architecture remains within the regulatory boundaries of advanced nutritional supplementation.

This distinction is fundamental.

The platform is designed to support physiological processes without triggering pharmacodynamic or drug-like intervention pathways.

Functional Safety by Design

Beyond regulatory eligibility, ABIMPROSYC incorporates a structured safety strategy at the formulation level.

Each composition is engineered to:

Avoid molecular redundancy or overlap

Minimize potential functional interaction risk

Maintain independent structural integrity of active families

Ensure traceability of each component within the delivery matrix

This systems-based design reduces complexity-related risks often observed in high-density multi-ingredient supplements.

Rather than combining ingredients for marketing breadth, the formulation emphasizes architectural coherence and functional compatibility.

Traceability and Transparency

Every component within ABIMPROSYC is selected and integrated under defined eligibility criteria. This approach ensures:

Ingredient-level documentation

Batch-level traceability

Functional categorization

Compliance alignment across international regulatory standards

In a market increasingly scrutinized for transparency and safety, structural defensibility is not optional — it is foundational.

A Compliance-Driven Innovation Model

Fourth Generation nutraceutical architecture must balance innovation with regulatory discipline.

ABIMPROSYC reflects this balance by integrating:

International safety eligibility frameworks

Non-pharmacological functional design

Interaction-aware formulation architecture

Documented traceability standards

The result is a platform positioned within advanced nutritional immunoceuticals while remaining firmly aligned with established regulatory safety boundaries.

Innovation without compliance is risk.

Compliance without structure is limitation.

ABIMPROSYC is designed to integrate both.
Oncovix Biological Cancer: #nutraceuticos #mexico #latinoamerica #salud #bienestar